BD VEO¿ INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE
Report
- Report Number
- 1920898-2023-00361
- Event Type
- Malfunction
- Date Received
- June 14, 2023
- Date of Event
- May 18, 2023
- Report Date
- August 17, 2023
- Manufacturer
- BD MEDICAL - DIABETES CARE
- Product Code
- FMF
- UDI-DI
- 00382903249107
- PMA / PMN Number
- K212499
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
- Health Professional
- Yes
Narratives
B.3. DATE OF EVENT: UNKNOWN. THE DATE RECEIVED BY MANUFACTURER HAS BEEN USED FOR THIS FIELD. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED. E.1. INITIAL REPORTER PHONE #: (B)(6). MULTIPLE LOT NUMBERS: THERE WERE MULTIPLE LOT NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR ADDITIONAL LOT NUMBER IS AS FOLLOWS: D4. MEDICAL DEVICE LOT #: 2122806. D4. MEDICAL DEVICE EXPIRATION DATE: 30-APR-2027. H4. DEVICE MANUFACTURE DATE:02-MAY-2022. D4. MEDICAL DEVICE LOT #: 2227420. D4. MEDICAL DEVICE EXPIRATION DATE: 31-AUG-2027. H4. DEVICE MANUFACTURE DATE: 15-AUG-2022.
THE FOLLOWING FIELDS WERE UPDATED DUE TO ADDITIONAL INFORMATION: D10: DEVICE AVAILABLE FOR EVAL YES, D10: RETURNED TO MANUFACTURER ON: 09-JUN-2023 H6: INVESTIGATION SUMMARY CUSTOMER RETURNED 5 SHELF CARTONS FROM LOT# 2122806 AND 3 SHELF CARTONS FROM LOT# 2227420 WITH (100) 0.3ML X 31G X 6MM SYRINGES INSIDE, REPORTING SCALE MARKING DEFECTIVE. THE RETURNED SYRINGES WERE VISUALLY EXAMINED AND OBSERVED NO ISSUES. THE (30) SYRINGES FROM EACH LOT WERE INSPECTED VIA GAUGE TO ENSURE CORRECT PLACEMENT OF THE GRADUATION MARKINGS AND OBSERVED THE RETURN SAMPLES FOUND TO BE WITHIN PERMITTED SPECIFICATIONS. FUNCTIONALITY TEST WAS PERFORMED AND OBSERVED NO ISSUES. NO DAMAGE TO THE NEEDLES OF ANY KIND WAS OBSERVED AND ALL FUNCTIONED AS INTENDED. HENCE, THE REPORTED ISSUE COULD NOT BE CONFIRMED BASED ON THE SAMPLES RETURN FOR INVESTIGATION. A REVIEW OF THE DEVICE HISTORY RECORD WAS COMPLETED FOR BATCH# 2122806 AND 2227420. ALL INSPECTIONS AND CHALLENGES WERE PERFORMED PER THE APPLICABLE OPERATIONS QC SPECIFICATIONS.
IT WAS REPORTED THAT 750 BD VEO¿ INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE EXPERIENCED SCALE MARKING ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: OF THE 300 COMPENSATION SAMPLES, 268 ARE "IN ACCURATE SCALE MARKS" AS IN PREVIOUS FILINGS. IN ADDITION TO THE COMPENSATION SAMPLE, THE SAME ISSUE OCCURS FOR 500 NEW PRODUCTS PURCHASED BY THE CUSTOMER. THIS IS THE THIRD CASE OF THE SAME CUSTOMER.
IT WAS REPORTED THAT 750 BD VEO¿ INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE EXPERIENCED SCALE MARKING ISSUE. THE FOLLOWING INFORMATION WAS PROVIDED BY THE INITIAL REPORTER: OF THE 300 COMPENSATION SAMPLES, 268 ARE "IN ACCURATE SCALE MARKS" AS IN PREVIOUS FILINGS. IN ADDITION TO THE COMPENSATION SAMPLE, THE SAME ISSUE OCCURS FOR 500 NEW PRODUCTS PURCHASED BY THE CUSTOMER. THIS IS THE THIRD CASE OF THE SAME CUSTOMER.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1409377 | BD VEO¿ INSULIN SYRINGES WITH BD ULTRA-FINE¿ NEEDLE | PISTON SYRINGE | FMF | BD MEDICAL - DIABETES CARE | 324910 | SEE H10 | 00382903249107 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Unknown |